MPO-pulsed DCs stimulated with the TLR9 ligand CpG (a component of DNA) stimulate Th1 responses and MPO autoimmunity and promote kidney injury in experimental anti-MPO GN (24). The gene discussed is TLR9; the disease is ganglioneuroma.